1. Penicillamine, characteristic degradation product ofpenicillin;Abraham, E.P.; Chain, E.; Baker, W.; Robinson, R.;Nature,1942
2. Controlled trial of D(-)penicillamine in severe rheumatoid arthritis;Andrews, F.M.; Freeman, A.H.; Golding, J.R.; Day, A.T.; Hill, A.G.S.; Camp, A.V.; Lewis-Faning, E.; Lyle, W.H.;Lancet,1973
3. Alclofenac in rheumatoid arthritis: an evaluation of its anti-inflammatory and analgesic effects;Aylward, M.;British Journal of Clinical Practice,1973
4. Studies on a 4-allylocy-3 chlorophenylacetic acid (alclofenac). A double blind comparison of alclofenac and aspirin in rheumatoid arthritis and effects of therapy on serum immunoglobulins and rheumatoid factor;Aylward, M.; Parker, R.J.; Maddock, J.;Annals of the Rheumatic Diseases,1974
5. Non-steroidal antirheumatic drugs in the treatment of rheumatoid arthritis: a long-term study of indomethacin and alclofenac;Aylward, M.; Parker, R.J.; Holly, F.; Maddock, J.; Davies, D.B.S.;British Medical Journal,1975